MedTech news

Reset all filters
Geography
Company
Refine search
Abbott fends off Chinese rival’s patent challenge at UPC
MedTech
The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.   18 August 2026
Invisalign maker secures first China win against clear aligner rival
MedTech
Clear aligner rivals are fighting over orthodontic technology across several major markets and the latest development in China has raised the stakes.   13 August 2026
Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie
Careers
Less than a month after the merger between Ashurst and Perkins Coie, the new team brings expertise in high-stakes patent matters—including medtech and biotech—in the US.   13 August 2026
Regulation & Industry
A federal judge has refused to disqualify Kirkland & Ellis from representing a healthcare tech company after a conflict check came under scrutiny.   7 August 2026
MedTech
A new UPC Court of Appeal ruling closes an important procedural gap, with significant implications for how in-house teams structure validity defences, manage litigation costs and prepare for appeals, says Florian Laus of Simmons & Simmons.   7 August 2026
Careers
With more than 25 years’ experience, the ex-EIP partner specialises in technology and life sciences, particularly SEPs and FRAND in the UK and Europe.   5 August 2026
MedTech
The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims.   3 August 2026
MedTech
A dispute over optical sensor technology in miniature hearing devices ended with the EPO revoking a patent, finding the invention obvious despite ruling it was new over the closest prior art.   30 July 2026
Careers
The engineer-turned-lawyer joins as a principal, bringing 15 years of experience advising on patent strategy across AI, software, and medical devices.   29 July 2026
MedTech
Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.   28 July 2026